Two junior research groups at Ruhr University Bochum, Germany, have developed a drug complex that kills cancer cells in such ...

Ambitious study will profile thousands of tumor samples to uncover novel biomarkers and therapeutic targets for cancer and ...

Cells and tissues surrounding a breast cancer tumor may hold critical information about how patients will respond to ...

UofL Health’s Brown Cancer Center recently became the first facility in the US to offer its patients access to an FDA ...

Brown Cancer Center recently became the first facility in the United States of America to offer its patients access to an FDA ...

In a Nutshell Turtles show extraordinarily low cancer prevalence — 0–1% compared to 10% in mammals. They likely evolved multiple genetic and cellular defenses, like extra tumor suppressor genes and ...

Allogeneic cell therapies are advancing in clinical trials, requiring oncologists and pathologists to understand the ...

Drs. Fatemeh Ardeshir-Larijani and Mohamed Abazeed discuss a validated AI model that can predict how patients with advanced ...

The Epstein-Barr virus is one of the most common and persistent human viruses in the world, according to the CDC.

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and ...

Recent research on MCL-1, a critical protein that is an attractive target for cancer drug development, helps explain why some ...

A study led by Karolinska Institutet in Sweden has demonstrated that the use of an AI tool can improve the pathologists' examinations of tissue samples obtained from skin cancer tumours, showing ...